| 000 | 01897 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516130833.0 | ||
| 264 | 0 | _c20130624 | |
| 008 | 201306s 0 0 spa d | ||
| 022 | _a1988-9518 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRubio-Terrés, Carlos | |
| 245 | 0 | 0 |
_a[Pharmacoeconomic analysis of the treatment of methicillin-resistant Staphylococcus aureus with daptomycin or vancomycin]. _h[electronic resource] |
| 260 |
_bRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia _cDec 2012 |
||
| 300 |
_a283-92 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDaptomycin _xadverse effects |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xeconomics |
| 650 | 0 | 4 |
_aEconomics, Pharmaceutical _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEndocarditis, Bacterial _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xeconomics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aRubio-Rodríguez, Darío | |
| 700 | 1 | _aMajos, Nuria | |
| 700 | 1 | _aGrau, Santiago | |
| 773 | 0 |
_tRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia _gvol. 25 _gno. 4 _gp. 283-92 |
|
| 999 |
_c22406303 _d22406303 |
||